Lisaftoclax Plus Chidamide and Rituximab in Relapsed or Refractory Diffuse Large B-cell Lymphoma
Clinical trial NCT07601607 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07601607
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-30
- Primary completion
- 2028-05-30
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.